FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to medicine, namely to pharmaceutical composition, which contains enzyme deoxyribonuclease or glycyrrhizic acid or its salts: ammonium or dipotassium or trisodium glycyrrhizinate, which can be applied in medicine for treatment and prevention of viral infections, caused by DNA-containing viruses, such as herpes, shingles, human papilloma, adenoviruses, etc. In an invention claimed is a pharmaceutical composition, which includes as active ingredients - 0.001-0.5 wt % of deoxyribonuclease (DNA-ase) and 0.001-0.5 wt % of glycyrrhizic acid or its salts: ammonium or dipotassium or trisodium glycyrrhizinate, as carriers: β-cyclodextrins or lecithins 0.001-5.0 wt %, a polymer carrier 0.05-1.00 wt % and acceptable excipients.
EFFECT: obtaining the pharmaceutical composition, which contains enzyme deoxyribonuclease and glycyrrhizic acid.
3 cl, 7 ex, 2 tbl
